These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 22044661

  • 1. Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS).
    Bhattacharya RK, Khera M, Blick G, Kushner H, Nguyen D, Miner MM.
    BMC Endocr Disord; 2011 Nov 01; 11():18. PubMed ID: 22044661
    [Abstract] [Full Text] [Related]

  • 2. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    J Sex Med; 2011 Nov 01; 8(11):3204-13. PubMed ID: 21834870
    [Abstract] [Full Text] [Related]

  • 3. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
    Bhattacharya RK, Khera M, Blick G, Kushner H, Miner MM.
    Clin Interv Aging; 2012 Nov 01; 7():321-30. PubMed ID: 22956867
    [Abstract] [Full Text] [Related]

  • 4. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G.
    Postgrad Med; 2013 Mar 01; 125(2):30-9. PubMed ID: 23816769
    [Abstract] [Full Text] [Related]

  • 5. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS).
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    Aging Male; 2012 Mar 01; 15(1):14-21. PubMed ID: 22092151
    [Abstract] [Full Text] [Related]

  • 6. 12-month observation of testosterone replacement effectiveness in a general population of men.
    Miner MM, Bhattacharya RK, Blick G, Kushner H, Khera M.
    Postgrad Med; 2013 Mar 01; 125(2):8-18. PubMed ID: 23816767
    [Abstract] [Full Text] [Related]

  • 7. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G, Khera M, Bhattacharya RK, Kushner H, Miner MM.
    Postgrad Med; 2013 Mar 01; 125(2):19-29. PubMed ID: 23816768
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Grober ED, Khera M, Soni SD, Espinoza MG, Lipshultz LI.
    Int J Impot Res; 2008 Mar 01; 20(2):213-7. PubMed ID: 17898800
    [Abstract] [Full Text] [Related]

  • 9. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    J Urol; 2011 Sep 01; 186(3):1005-11. PubMed ID: 21788049
    [Abstract] [Full Text] [Related]

  • 10. Total testosterone levels are correlated to metabolic syndrome components.
    Blaya R, Thomaz LD, Guilhermano F, Paludo Ade O, Rhoden L, Halmenschlager G, Rhoden EL.
    Aging Male; 2016 Jun 01; 19(2):85-9. PubMed ID: 26961662
    [Abstract] [Full Text] [Related]

  • 11. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS).
    Blick G, Khera M, Bhattacharya RK, Nguyen D, Kushner H, Miner MM.
    Pain Med; 2012 May 01; 13(5):688-98. PubMed ID: 22536837
    [Abstract] [Full Text] [Related]

  • 12. Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies.
    Brand JS, Rovers MM, Yeap BB, Schneider HJ, Tuomainen TP, Haring R, Corona G, Onat A, Maggio M, Bouchard C, Tong PC, Chen RY, Akishita M, Gietema JA, Gannagé-Yared MH, Undén AL, Hautanen A, Goncharov NP, Kumanov P, Chubb SA, Almeida OP, Wittchen HU, Klotsche J, Wallaschofski H, Völzke H, Kauhanen J, Salonen JT, Ferrucci L, van der Schouw YT.
    PLoS One; 2014 May 01; 9(7):e100409. PubMed ID: 25019163
    [Abstract] [Full Text] [Related]

  • 13. Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).
    Shigehara K, Konaka H, Nohara T, Izumi K, Kitagawa Y, Kadono Y, Iwamoto T, Koh E, Mizokami A, Namiki M.
    Andrologia; 2018 Feb 01; 50(1):. PubMed ID: 28497534
    [Abstract] [Full Text] [Related]

  • 14. [The relationship between testosterone deficiency and metabolic syndrome in obese men].
    Tylińska M, Broncel M.
    Pol Merkur Lekarski; 2013 Jan 01; 34(199):24-8. PubMed ID: 23488280
    [Abstract] [Full Text] [Related]

  • 15. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies.
    Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT.
    Int J Epidemiol; 2011 Feb 01; 40(1):189-207. PubMed ID: 20870782
    [Abstract] [Full Text] [Related]

  • 16. Total testosterone is the most valuable indicator of metabolic syndrome among various testosterone values in middle-aged Japanese men.
    Tanabe M, Akehi Y, Nomiyama T, Murakami J, Yanase T.
    Endocr J; 2015 Feb 01; 62(2):123-32. PubMed ID: 25342164
    [Abstract] [Full Text] [Related]

  • 17. Lower levels sex hormone-binding globulin independently associated with metabolic syndrome in pre-elderly and elderly men in China.
    Pang XN, Hu Y, Yuan Y, Shen JP, Zha XY, Sun X.
    J Geriatr Cardiol; 2013 Mar 01; 10(1):28-33. PubMed ID: 23610571
    [Abstract] [Full Text] [Related]

  • 18. Testosterone Replacement Therapy and Components of the Metabolic Syndrome.
    Anaissie J, Roberts NH, Wang P, Yafi FA.
    Sex Med Rev; 2017 Apr 01; 5(2):200-210. PubMed ID: 28202344
    [Abstract] [Full Text] [Related]

  • 19. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
    Wu XY, Mao JF, Lu SY, Zhang Q, Shi YF.
    Chin Med J (Engl); 2009 Dec 05; 122(23):2846-50. PubMed ID: 20092788
    [Abstract] [Full Text] [Related]

  • 20. Absorption of testosterone gel 1% (Testim) from three different application sites.
    Guay AT, Smith TM, Offutt LA.
    J Sex Med; 2009 Sep 05; 6(9):2601-10. PubMed ID: 19549089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.